I Pomeranz

975 citations
18 papers · 732 indexed · h-index 11

Impact in

Papers in

I Pomeranz

18 papers receiving 709 citations

Peers

I Pomeranz
Comparison fields: 5 of 58
  • Gastroenterology 80
  • Genetics 363
  • Epidemiology 319
  • Surgery 316
  • Pulmonary and Respiratory Medicine 215
Replace C Lenaerts with:
C Lenaerts France
A. Massari Italy
Emily C L Wong Canada
Rosalind Sim United Kingdom
C. J. J. Mulder Netherlands
Rivka Shapiro Israel
Yoon‐Tae Jeen South Korea
Aykut Ferhat Çelık Türkiye
J L Dupas France
Elisabeth Macken Belgium
I Pomeranz relative to C Lenaerts France C Lenaerts's profile →
Citations per field
00.5×1.5×
C Lenaerts · 1×
Citations per year

Countries citing papers authored by I Pomeranz

Since Specialization
Citations

This map shows the geographic impact of I Pomeranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Pomeranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Pomeranz more than expected).

Fields of papers citing papers by I Pomeranz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Pomeranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Pomeranz. The network helps show where I Pomeranz may publish in the future.

Co-authors

The 25 scholars most cited alongside I Pomeranz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I Pomeranz Line = papers co-authored together I Pomeranz links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 201324
2
[Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease].
20121
3 200912
4
[ERCP for benign disease in the elderly: a good prognosis].
20062
5 20031
6
Secondary aortoduodenal fistula.
20022
7 20011
8 200024
9
Cyclosporin for severe ulcerative colitis.
200015
10 199912
11
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
1997161
12 1996205
13 199618
14 19917
15 198619
16 19852
17 1985200
18 198326

About I Pomeranz

I Pomeranz is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Surgery, Rheumatology and Gastroenterology, having authored 18 papers that have together received 732 indexed citations. Recurring topics across this work include Gallbladder and Bile Duct Disorders (5 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Inflammatory Bowel Disease (3 papers), Eosinophilic Esophagitis (2 papers), Biliary and Gastrointestinal Fistulas (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Microscopic Colitis (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Gastroenterology (80 citations), Genetics (363 citations), Epidemiology (319 citations), Surgery (316 citations) and Pulmonary and Respiratory Medicine (215 citations). I Pomeranz has collaborated with scholars based in Israel and Canada. Frequent co-authors include Eldon A. Shaffer, Shmuel Odes, Daniel Keter, Tuvia Gilat, Nadir Arber, Rami Eliakim, Menachem Moshkowitz, Joseph S. Davison, Ran Oren and J Patz. Their work appears in journals such as Gastroenterology, Digestive Diseases and Sciences, Surgical Endoscopy, Canadian Journal of Physiology and Pharmacology and Journal of Surgical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026